SEC FORM 3

Please wait

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lindsay Brigitte Ute

(Last)

(First)

(Middle)

11055 FLINTKOTE AVENUE

(Street)

SAN DIEGO

92121

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/27/2026

3. Issuer Name and Ticker or Trading Symbol
Cardiff Oncology, Inc. [ CRDF ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Accounting Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	27,431	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options	⁽¹⁾	01/23/2028	Common Stock	1,753	$21.6	D
Stock Options	⁽²⁾	06/20/2029	Common Stock	89,469	$2.48	D
Stock Options	⁽³⁾	06/17/2030	Common Stock	96,192	$2.6	D
Stock Options	⁽⁴⁾	06/10/2031	Common Stock	154,704	$7.98	D
Stock Options	⁽⁵⁾	03/09/2032	Common Stock	131,568	$2.5	D
Stock Options	⁽⁶⁾	03/15/2033	Common Stock	90,288	$1.72	D
Stock Options	⁽⁷⁾	03/17/2034	Common Stock	95,040	$3.51	D
Stock Options	⁽⁸⁾	03/11/2035	Common Stock	166,320	$3.58	D

Explanation of Responses:

1. 1,198 vested on January 23, 2018. 185 vested on January 23, 2019, 2020 and 2021.

2. 29,823 vested on June 20, 2020, 2021 and 2022.

3. 32,064 vested on June 17, 2021, 2022 and 2023.

4. 38,676 vested on June 10, 2022 and 3,223 vested monthly for 36 months thereafter.

5. 32,892 vested on March 9, 2023 and 2,741 vest monthly for 36 months thereafter.

6. 22,572 vested on March 15, 2024 and 1,881 vest monthly for 36 months thereafter.

7. 23,760 vested on March 7, 2025 and 1,980 vest monthly for 36 months thereafter.

8. 41,580 vest on March 11, 2026 and 3,465 vest monthly for 36 months thereafter.

	/s/ Brigitte Lindsay	02/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.